Mitomycin C ( DrugBank: Mitomycin, Mitomycin C )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 94 | Primary sclerosing cholangitis | 1 |
94. Primary sclerosing cholangitis
Clinical trials : 142 / Drugs : 113 - (DrugBank : 37) / Drug target genes : 19 - Drug target pathways : 139
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01688024 (ClinicalTrials.gov) | September 2012 | 10/9/2012 | Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis | Phase 2 Study of Mitomycin C Therapy for Biliary Strictures in Patients With Primary Sclerosing Cholangitis | Primary Sclerosing Cholangitis | Drug: Mitomycin C;Drug: Normal saline | Li, Zhiping, M.D. | Johns Hopkins University | Recruiting | 18 Years | N/A | Both | 130 | Phase 2 | United States |